
DYNE THERAPEUTICS INC
DYNNASDAQ🏆 #1262 by market capEarnings Nov 4US Equity
$26.82▲ $0.10 (+0.39%)
Live1h▼ 0.4%
24h▲ 0.4%
7d▲ 2.6%
14d▲ 6.8%
30d▲ 13.4%
1y▲ 130.7%
🏦Market Cap
$5.01B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
57
Weak
📊
Analyst Ratings
Price
$26.82
Total
14
Raised
2
Lowered
0
Avg PT
$35.00
H / L
$45 / $24
| Institution | Action | Rating | Date |
|---|---|---|---|
Morgan Stanley | Reiterated | Overweight | 2026-07-31 |
RBC Capital | Reiterated | Outperform | 2026-07-30 |
Evercore ISI Group | Reiterated | Outperform | 2026-05-15 |
Bernstein | Reiterated | Market Perform | 2026-05-13 |
Chardan Capital | Reiterated | Buy | 2026-03-09 |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-03 |
JP Morgan | Reiterated | Neutral | 2026-01-20 |
Stifel | Reiterated | Buy | 2025-12-11 |
Oppenheimer | Upgraded | Perform → Outperform | 2025-12-10 |
Raymond James | Upgraded | Outperform → Strong Buy | 2025-08-25 |
Guggenheim | Reiterated | Buy | 2025-06-18 |
Baird | Reiterated | Outperform | 2025-06-18 |
Piper Sandler | Reiterated | Overweight | 2025-02-28 |
Jefferies | Reiterated | Buy | 2024-05-20 |
One row per institution, most recent rating